Nifty Surpasses 22,300 Mark; Sensex Climbs 655 Pointsby Mark Eisenberg 28.03.2024Despite facing resistance at the 47,500 mark, the Nifty index had a strong performance with a nearly 29% USD return. ...
Nifty Soars Above 22,300, Sensex Up 655pts – All Sectors in Greenby Mark Eisenberg 28.03.2024The Nifty index in India saw a positive return and performed well, but faced resistance at the 47,500 level. Breaking ...
IU Bird Researchers Create Solar Bird App for Eclipse Studyby Lilu Anderson 28.03.2024Researchers are excited to observe bird behavior during the eclipse, expecting them to stop singing and act surprised. The Solar ...
First Savings Financial Group Inc: Stock Price Rises 2.60% amid Positive Financial Reportby Terry Bingman 27.03.2024First Savings Financial Group Inc (FSFG) stock price is $16.95, up 2.60%. Company profile includes banking services with assets of ...
How I Retired at 29: Tips for Young Investorsby Mark Eisenberg 27.03.2024You can apply directly for Ph.D. programs in the US without a master's degree. Get a free master's degree two ...
SpaceX’s Massive Starship Rocket To Launch From Texasby Lilu Anderson 07.03.2024SpaceX is set to launch the giant Starship rocket from Texas, with plans to splash down in the Indian Ocean. ...
SpaceX Sets Target Date for Third Starship Test Flightby Lilu Anderson 07.03.2024SpaceX plans to launch the third test flight of its Starship rocket next week, aiming to achieve new milestones and ...
MJ Companies Names Brian Stoll as New CFOby Mark Eisenberg 07.03.2024Indianapolis-based MJ Companies has appointed Brian Stoll as its new CFO. Stoll comes with 20 years of experience as CFO ...
Mubadala and Bpifrance Co-Invest in Africa’s Largest Tech VC Fundby Lilu Anderson 06.03.2024Abu Dhabi's Mubadala and France's Bpifrance will invest in Partech's Africa-focused VC fund, the largest of its kind, with €280m ...
AI in Drug Discovery Market Growth and Challenges: Forecast Study 2030by Lilu Anderson 06.03.2024The growing AI in drug discovery market is driven by the increasing amount of data in drug development. However, restraints ...